Comparison between Nectar Lifesciences IPO and Yash Papers FPO.
Nectar Lifesciences IPO is a Mainboard Fixed Price IPO proposed to list at BSE, NSE while Yash Papers FPO is a Mainboard Fixed Price proposed to list at BSE.
| Nectar Lifesciences IPO | Yash Papers FPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | Mainboard | Mainboard |
| Issue Type | IPO | FPO |
| Process Type | Bookbuilding | Fixed Price |
| Listing At | BSE, NSE | BSE |
| Lead Managers | ICICI Securities Ltd. | Karvy Investor Services Ltd. |
| Registrar | Kfin Technologies Ltd. | Skyline Financial Services Pvt.Ltd. |
| Market Maker | ||
| DRHP | DRHP  | DRHP |
| RHP | RHP | |
| Final Prospectus | Final Prospectus | |
| Anchor Investor | ||
| IPO Allotment URL |
The total issue size of Nectar Lifesciences IPO is up to ₹92.88 Cr whereas the issue size of the Yash Papers FPO is up to ₹18.82 Cr. The final issue price of Nectar Lifesciences IPO is ₹240.00 per share and of Yash Papers FPO is ₹14.00 per share.
| Nectar Lifesciences IPO | Yash Papers FPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹200.00 per share | |
| Issue Price (Upper) | ₹240.00 per share | |
| Issue Price (Final) | ₹240.00 per share | ₹14.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | ||
| Fresh Issue Size | 38,70,000 shares | 1,34,40,000 shares |
| Fresh Issue Size (Amount) | up to ₹92.88 Cr | up to ₹18.82 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 38,70,000 shares | 1,34,40,000 shares |
| Issue Size Total (Amount) | up to ₹92.88 Cr | up to ₹18.82 Cr |
Nectar Lifesciences IPO opens on Jun 22, 2005, while Yash Papers FPO opens on Jun 30, 2005. The closing date of Nectar Lifesciences IPO and Yash Papers FPO is Jun 28, 2005, and Jul 08, 2005, respectively.
Nectar Lifesciences IPO P/E ratio is , as compared to Yash Papers FPO P/E ratio of .
| Nectar Lifesciences IPO | Yash Papers FPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)
| Company Financials (Restated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 89.08 | 40.451 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 65.93 | 23.83 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 31.3 | 18.80 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Nectar Lifesciences IPO Retail Individual Investors (RII) are offered 13,54,500 shares while in Yash Papers FPO retail investors are offered 13,54,500 shares. Qualified Institutional Buyers (QIB) are offered 19,35,000 shares in Nectar Lifesciences IPO and 0 shares in Yash Papers FPO.
| Nectar Lifesciences IPO | Yash Papers FPO | |
|---|---|---|
| Anchor Investor Reservation | 0 shares | 0 shares |
| Market Maker Reservation | 0 shares | 0 shares |
| QIB | 19,35,000 shares | 0 shares |
| NII | 5,80,500 shares | 67,20,000 shares |
| RII | 13,54,500 shares | 67,20,000 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 38,70,000 shares | 1,34,40,000 shares |
Nectar Lifesciences IPO subscribed in total, whereas Yash Papers FPO subscribed .
